コンテンツへスキップ
Merck

Studies on the peptidase activity of transthyretin (TTR).

Biochimie (2012-09-25)
Iuri Estrada Gouvea, Marcia Yuri Kondo, Diego M Assis, Fabiana Madureira Alves, Márcia Almeida Liz, Maria Aparecida Juliano, Luiz Juliano
要旨

Transthyretin (TTR) is a plasma protein transporter of thyroxine (T(4)) and retinol and also has peptidase activity. In order to characterize TTR peptidase activity we used fluorescence resonance energy transfer (FRET) peptides derived from Abz-KLRSSK-Q-EDDnp and from two portion-mixing libraries as substrates. Most of the susceptible FRET peptides were cleaved at more than one peptide bond, without particular substrate specificity. The more relevant observation was that the peptides containing E or D were cleaved at only one peptide bond and TTR was competitively inhibited by glutathione analog peptide γ-E-A-G-OH that contains two free carboxyl groups. The dependence on ionic interactions of TTR hydrolytic activity was confirmed by the large inhibitory effects of salt and ionic surfactants. TTR was not inhibited by any usual peptidase inhibitors, except by ortho-phenanthroline and EDTA. The mechanism of TTR catalysis was explored by the pH-profile of TTR hydrolytic activity in different temperatures and by proton inventory. The obtained pK and heat of ionization values suggest that a carboxylate and an ammonium group, possibly from a lysine side chain are involved. These results support the recently proposed inducible metalloprotease mechanism for TTR based on its 3D structure in presence of Zn(2+) and a series of point mutations [Liz et al., Biochem. J 443 (2012) 769-778].

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
フェロイン指示薬 溶液, 0.1 wt. % in H2O
Sigma-Aldrich
フェロイン指示薬 溶液